Drug discovery from medicinal plants

Current research in drug discovery from medicinal plants involves a multifaceted approach combining botanical, phytochemical, biological, and molecular techniques. Medicinal plant drug discovery continues to provide new and important leads against various pharmacological targets including cancer, HIV/AIDS, Alzheimer's, malaria, and pain. Several natural product drugs of plant origin have either recently been introduced to the United States market, including arteether, galantamine, nitisinone, and tiotropium, or are currently involved in late-phase clinical trials. As part of our National Cooperative Drug Discovery Group (NCDDG) research project, numerous compounds from tropical rainforest plant species with potential anticancer activity have been identified. Our group has also isolated several compounds, mainly from edible plant species or plants used as dietary supplements, that may act as chemopreventive agents. Although drug discovery from medicinal plants continues to provide an important source of new drug leads, numerous challenges are encountered including the procurement of plant materials, the selection and implementation of appropriate high-throughput screening bioassays, and the scale-up of active compounds.     

Twenty years of research into medicinal plants: Results and perspectives

Over the years 1981 to 2001 there has been a rapid evolution of research into medicinal plants. The major improvement has been the introduction of simple and predictive bioassays for bioactivity-guided isolation. Radical developments in separation methods have also taken place. Another important addition has been the development of hyphenated techniques involving HPLC: LC/UV, LC/MS, LC/MSⁿ and LC/NMR. These are indispensable nowadays for the early detection and identification of new compounds in crude plant extracts. Hyphenated techniques allow an efficient targeted isolation approach for the discovery of new lead compounds. Other areas of increasing importance include the investigation of toxic constituents of plants and phytomedicines, and the effects of genetic modifications on plant secondary metabolites. This revised version was published online in June 2006 with corrections to the Cover Date.     

Biological screening of Brazilian medicinal plants

In this study, we screened sixty medicinal plant species from the Brazilian savanna ("cerrado") that could contain useful compounds for the control of tropical diseases. The plant selection was based on existing ethnobotanic information and interviews with local healers. Plant extracts were screened for: (a) molluscicidal activity against Biomphalaria glabrata, (b) toxicity to brine shrimp (Artemia salina L.), (c) antifungal activity in the bioautographic assay with Cladosporium sphaerospermum and (d) antibacterial activity in the agar diffusion assay against Staphylococcus aureus, Escherichia coli, Bacillus cereus and Pseudomonas aeruginosa. Forty-two species afforded extracts that showed some degree of activity in one or more of these bioassays.     

药用植物引种驯化原理研究

药用植物作为一种重要的资源,其价值主要体现在具有防治疾病的功能,这种功能的物质基础在于植物内部合成的有效成分。药用植物引种驯化的主要目的是为了扩大其资源量,能更好地开发药用植物和可持续利用。因此,药用植物引种驯化不仅要保证药用植物在引种地的生长发育和繁殖,还需保证药效成分的维持与提高,其引种驯化成功的标志是从"药效"到"药效"。为此,该研究在对近年来药用植物药效成分的形成与稳定、药用植物的发源以及药用植物引种与驯化等方面进行综述整理的基础上,提出了药用植物引种驯化的原理,对于目前大量药效成分复杂不清的药用植物,不提倡复杂引种驯化。针对这类药用植物提出了药用植物发源中心假设,即先确定其发源中心,在此中心内收集引种群体和生态各因子的信息,以此为基础,在引种地上保证与药效形成和稳定相关因子不变,确保引种驯化后药用植物的药用功效不减弱或丧失,并通过多种方法综合评价药用植物的药效,从而达到药用植物引种驯化的目的。     

青藏高原药用植物资源及其保护与利用

本文从青藏高原药用植物资源的分布情况,资源特点以及相应的保护利用等方面简要的概括了近来的研究新进展,旨在理清相关研究情况,为相应的研究工作提供参考。     

Pinellia ternata agglutinin expression in chloroplasts confers broad spectrum resistance against aphid, whitefly, Lepidopteran insects, bacterial and viral pathogens

Broad spectrum protection against different insects and pathogens requires multigene engineering. However, such broad spectrum protection against biotic stress is provided by a single protein in some medicinal plants. Therefore, tobacco chloroplasts were transformed with the agglutinin gene from Pinellia ternata (pta), a widely cultivated Chinese medicinal herb. Pinellia ternata agglutinin (PTA) was expressed up to 9.2% of total soluble protein in mature leaves. Purified PTA showed similar hemagglutination activity as snowdrop lectin. Artificial diet with purified PTA from transplastomic plants showed marked and broad insecticidal activity. In planta bioassays conducted with T0 or T1 generation PTA lines showed that the growth of aphid Myzus persicae (Sulzer) was reduced by 89%-92% when compared with untransformed (UT) plants. Similarly, the larval survival and total population of whitefly (Bemisia tabaci) on transplastomic lines were reduced by 91%-93% when compared with UT plants. This is indeed the first report of lectin controlling whitefly infestation. When transplastomic PTA leaves were fed to corn earworm (Helicoverpa zea), tobacco budworm (Heliothis virescens) or the beet armyworm (spodoptera exigua), 100% mortality was observed against all these three insects. In planta bioassays revealed Erwinia population to be 10,000-fold higher in control than in PTA lines. Similar results were observed with tobacco mosaic virus (TMV) challenge. Therefore, broad spectrum resistance to homopteran (sap-sucking), Lepidopteran insects as well as anti-bacterial or anti-viral activity observed in PTA lines provides a new option to engineer protection against biotic stress by hyper-expression of an unique protein that is naturally present in a medicinal plant.     

Bioassays for incompatibility

Summary Self-incompatibility is a form of plant growth regulation acting on pollen and the pollen tube. It could therefore be amenable to study by bioassay techniques, which have been used successfully in the past to show the existence of other plant growth regulators and to assist in their purification. The genetics of self-incompatibility is well understood, and yet there have been difficulties in applying bioassays to the study of the supposed gene products. This review examines published accounts of attempts made to use the bioassay technique in the study of self-incompatibility. In general, bioassays for sporophytic incompatibility have been more successful than gametophytic tests, but none is entirely convincing. Despite this, the authors believe it is worthwhile for those involved with fertilization incompatibility research to persist in trying to improve the bioassay for use as an analytical tool.     

药用植物学立体化课程体系的构建与实践

药用植物学是医学院中药、药学等相关专业和高等农业院校中药资源开发与利用等专业的专业基础课,是培养相关专业学生掌握和运用药用植物形态解剖学及系统分类学的基本知识和技能,准确识别和鉴定药用植物种类,保证临床用药准确有效的重要课程。课题组通过整合药用植物学教学内容,建立多元化的教学方法,构建多层次实践教学体系,建立合理的综合性考核评价体系,培养学生双创能力。     

京族药用红树林民族植物学知识及现状

京族是我国唯一的海洋民族,在长期与红树林为伴的生存环境中,积累了丰富的利用红树林植物的民族植物学知识。然而,这些知识至今仍不为外界所知。为掌握京族药用红树林民族植物学知识和现状,该研究采用民族植物学和植物分类学方法,调查京族药用红树林知识中的红树林植物种类,记录其具体药用用途,并分析其生存现状及其中包含的可持续利用红树林植物资源经验。结果表明:共记录到京族药用红树林植物15种隶属于10科,具体药用用途共49种。其中,20种已有报道,29种未见报道;通过京族对红树林药用知识认知程度和依赖程度的调查还表明,京族历史上依赖本民族草医的情形已经基本消失,对红树林医药的依赖性和需求性也在消失。最后,剖析了京族在药用红树林植物选择与采集中的可持续利用经验。该研究结果不仅补充和拓宽了红树林民间药物的利用知识,而且为红树植物资源的管理与可持续利用提供了新视角。     

Functional correlates of allelopathic potential in a successional plant community

Allelopathy, plant–plant interactions mediated through chemical production, is an active area of ecological research. Despite this widespread interest, we still lack community scale information on the prevalence of this interaction and the types of species that may be expected to be allelopathic. To address this research need, the allelopathic potential of 65 plant species from all stages of succession in the Piedmont region of New Jersey, USA, was determined with laboratory bioassays. The strength of each species’ allelopathic activity was then related to life form, origin, and fundamental plant traits. The vast majority of species tested exhibited significant allelopathic effects in the bioassays, with many of these having fairly strong effects. Overall, the allelopathic potential of species decreased with life span, roughly following the successional transitions from short-lived to long-lived herbs and to woody species. Herbaceous species on average were more allelopathic than woody species, but there was no difference between native and non-native species once life form was accounted for. In a principal components analysis, allelopathy was associated with other plant traits, but these relationships differed between woody and herbaceous species. Allelopathic potential was positively associated with plant height in herbaceous species, but negatively associated with height, leaf mass, and seed mass in woody species. These results indicate that allelopathy may be a quite common ecological strategy in plants and is equally common in both native and non-native species. The linkage of allelopathy with other plant functional traits suggests that allelopathy can and should be integrated into the broader suite of plant strategies that are studied.     

Adaptive mechanisms of medicinal plants along altitude gradient: contribution of proteomics

Medicinal plants are a rich source of secondary metabolites extensively used in traditional health care systems. High altitude biodiversity encompasses the diversified and valuable medicinal plant species. The extreme environmental conditions of high altitude region viz. fluctuating temperatures, high UV radiation, salinity, low oxygen concentration, and high wind velocity limits the plant growth and distribution. Yet, how medicinal plants respond to these extreme conditions is not sufficiently understood. Therefore, addressing plant acclimation to different stresses presents an opportunity to unravel adaptive mechanism of medicinal plants along altitude gradient. This article reviews the recently published research that highlights the major role of proteins in plant adaptation to extreme environmental conditions. In the last few decades, climate change has made a profound impact on high altitude plants. Stress conditions alter cellular homeostasis of plants. With the advent of proteomics, it has become evident that stresses induce changes in proteome by synthesis/expression of novel stress responsive proteins. These proteins constitute a highly organized, complex network that leads to changes in the molecular, biochemical, physiological, and morphological responses of plants. Herein, we comprehensively discuss the proteomics of medicinal plants and its role in adaptation along altitude gradient. This review aims to provide impetus to current research in medicinal plants ranging from developmental to stress biology and to generate basis for genetic engineers and plant breeders to produce next-generation medicinal plants.     

Comparison of osmotic and allelopathic effects of grass leaf extracts on grass seed germination and radicle elongation

The influence of osmotic effects of aqueous plant extracts on the results of allelopathy bioassays was investigated for four pasture grass species. It was found that allelopathic effects were substantially overestimated when osmotic effects were not taken into account. It is concluded that bioassays using aqueous plant extracts are more realistic when osmotically adjusted control values (with the same osmotic potential as the plant extract being tested) are used.     

An ethnobotanical survey of indigenous knowledge on medicinal plants used by the traditional healers of the Lwamondo area,Limpopo province,South Africa

The use of medicinal plants in the treatment and prevention of diseases is attracting the attention of scientists worldwide. Approximately 3000 plant species are currently used by an estimated 200,000 indigenous traditional healers in South Africa. The specific part of the plant used for medicinal applications varies from species to species, and from one traditional healer to another. This study was carried out to explore and record those plants and plant parts used for treating various human ailments by the traditional healers of the Lwamondo area in the Limpopo province, South Africa for medicinal purposes. Ethnobotanical data were collected from 30 traditional healers (24 females and 6 males) in the Lwamondo area of Venda, by means of a data capture questionnaire focusing on the local names of the medicinal plants, their medicinal uses, the plant parts used, and methods of preparation and of administering treatments to patients. The survey identified 16 medicinal plants from 7 families, with 14 genera, used to treat a range of ailments in the Lwamondo area. The Fabaceae family was the most commonly used plant family representing 43.8% of all the medicinal plants species recorded by this study, followed by the Varbenaceae family at 18.8%. The plant parts most frequently used were the roots (44.5%), followed by the leaves (25.9%), bark (14.8%), the whole plant (11%), and flowers (3.7%). Most of the traditional healers obtained their extracts by boiling the medicinal plants. The most often recurring ailment treated by healers was stomach problems, using 31.3% of all the medicinal plants reported in this study for preparing such treatments. The following medicinal plants were covered by this study: Annona senegalensis, Schkuhria pinnata, Diospyros mespiliformis, Piliostigma thonningii, Senna obtusifolia, Bauhinia galpinii. The rural communities of the Lwamondo area possess a wealth of information on medicinal plants and their applications. This ethnobotanical survey can help scientists identify for further research those plants whose medicinal properties may be useful in the development of new drugs.     

新疆北塔山地区药用植物资源及多样性分析

经野外调查、查阅文献和标本鉴定,对新疆北塔山地区药用植物资源及多样性进行了研究。结果显示,该研究区内共有药用植物24科44属60种,其中珍稀濒危药用植物16种,集中分布于单种科和单种属内;区系成分以温带成分为主且与地中海、西亚至中亚分布及其变型联系紧密,热带成分有微弱渗入;生活型以多年生草本植物类型为主,共计29种,占该研究区总种数的48.33%,兼具部分一年生草本和灌木类型;生态型以中生植物为主,但旱生性特征明显;植物的药用部位多样,但集中于全草、根类和茎叶,分别为43.33%、15%和11.66%。本研究为北塔山地区药用植物的保护提供了重要的本底资料,也为该地区生物多样性的研究提供了科学依据。     

药用植物内生真菌研究现状和发展趋势

药用植物内生真菌普遍存在于健康植物组织和器官中,种类繁多,分布广泛。到目前为止,人们已从大量药用植物中分离出不同类型的内生真菌,这些植物广泛分布于除南极洲以外的各种陆地生态系统中。随着现代科学技术的迅速发展,药用植物内生真菌的研究也取得了长足的进步。由于内生真菌对于药用植物的重要性,其相关研究也受到了世界各国学者的高度关注。本文总结现阶段药用植物内生真菌相关研究,并对未来研究的发展趋势做出展望。     

Medical ethnobotany of the Albanian Alps in Kosovo

Background

The boreal forest of Canada is home to several hundred thousands Aboriginal people who have been using medicinal plants in traditional health care systems for thousands of years. This knowledge, transmitted by oral tradition from generation to generation, has been eroding in recent decades due to rapid cultural change. Until now, published reviews about traditional uses of medicinal plants in boreal Canada have focused either on particular Aboriginal groups or on restricted regions. Here, we present a review of traditional uses of medicinal plants by the Aboriginal people of the entire Canadian boreal forest in order to provide comprehensive documentation, identify research gaps, and suggest perspectives for future research.

Methods

A review of the literature published in scientific journals, books, theses and reports.

Results

A total of 546 medicinal plant taxa used by the Aboriginal people of the Canadian boreal forest were reported in the reviewed literature. These plants were used to treat 28 disease and disorder categories, with the highest number of species being used for gastro-intestinal disorders, followed by musculoskeletal disorders. Herbs were the primary source of medicinal plants, followed by shrubs. The medicinal knowledge of Aboriginal peoples of the western Canadian boreal forest has been given considerably less attention by researchers. Canada is lacking comprehensive policy on harvesting, conservation and use of medicinal plants. This could be explained by the illusion of an infinite boreal forest, or by the fact that many boreal medicinal plant species are widely distributed.

Conclusion

To our knowledge, this review is the most comprehensive to date to reveal the rich traditional medicinal knowledge of Aboriginal peoples of the Canadian boreal forest. Future ethnobotanical research endeavours should focus on documenting the knowledge held by Aboriginal groups that have so far received less attention, particularly those of the western boreal forest. In addition, several critical issues need to be addressed regarding the legal, ethical and cultural aspects of the conservation of medicinal plant species and the protection of the associated traditional knowledge.     

Zebrafish bioassay-guided natural product discovery: isolation of angiogenesis inhibitors from East African medicinal plants

Natural products represent a significant reservoir of unexplored chemical diversity for early-stage drug discovery. The identification of lead compounds of natural origin would benefit from therapeutically relevant bioassays capable of facilitating the isolation of bioactive molecules from multi-constituent extracts. Towards this end, we developed an in vivo bioassay-guided isolation approach for natural product discovery that combines bioactivity screening in zebrafish embryos with rapid fractionation by analytical thin-layer chromatography (TLC) and initial structural elucidation by high-resolution electrospray mass spectrometry (HRESIMS). Bioactivity screening of East African medicinal plant extracts using fli-1:EGFP transgenic zebrafish embryos identified Oxygonum sinuatum and Plectranthus barbatus as inhibiting vascular development. Zebrafish bioassay-guided fractionation identified the active components of these plants as emodin, an inhibitor of the protein kinase CK2, and coleon A lactone, a rare abietane diterpenoid with no previously described bioactivity. Both emodin and coleon A lactone inhibited mammalian endothelial cell proliferation, migration, and tube formation in vitro, as well as angiogenesis in the chick chorioallantoic membrane (CAM) assay. These results suggest that the combination of zebrafish bioassays with analytical chromatography methods is an effective strategy for the rapid identification of bioactive natural products.     

五加科植物发状根诱导研究进展

五加科植物多为重要的中药材,利用发根农杆菌诱导五加科药用植物产生发状根,并从中获取有用的次生代谢产物,是保护五加科珍稀药用植物资源和实现有效次生代谢物质工业化生产的有效途径。该文在概述发根农杆菌转化药用植物研究历程和转化机理研究的基础上,对近年来在发根农杆菌诱导五加科植物的种类及诱导率、影响发根农杆菌诱导五加科植物的各种因素和利用发根农杆菌诱导五加科植物获得再生植株等方面研究进行了重点分析,并对今后亟需研究的几个重点方向进行了展望,以期为五加科药用植物的良性开发和合理利用提供参考。     

Gitksan medicinal plants-cultural choice and efficacy

Background

The use of plants for healing by any cultural group is integrally related to local concepts of the nature of disease, the nature of plants, and the world view of the culture. The physical and chemical properties of the plants themselves also bear on their selection by people for medicines, as does the array of plants available for people to choose from. I examine use of medicinal plants from a "biobehavioral" perspective to illuminate cultural selection of plants used for medicine by the Gitksan of northwestern British Columbia, Canada.

Methods

Consultant consensus, "intercultural consensus", independent use of the same plants by other cultural groups, and phytochemistry and bioassay results from the literature, were employed in analysis of probable empirical efficacy of plant uses.

Results

70% of 37 Gitksan medicinal plants were used similarly by other cultures where direct diffusion is not known to have occurred; eleven plants, including the eight most frequently mentioned medicinal plants, also show active phytochemicals or bioassays indicating probable physiologically based therapeutic effects.

Conclusion

Analysis of intercultural consensus revealed that the majority of cultures in the British Columbia region within the plant ranges use the same plants, or closely related species, in similar ways. The rigor of this analysis is effected by the lack of consistent data on all taxa of interest for all cultures within the region.     

Sustainable Utilization and Economic Development of Some Plant Resources in Northern Pakistan

Overshadowed by the vast impact that habitat loss has on targeted plant species survival, it is easy to overlook the fact that utilization and harvesting of species can often result in their genetic depletion and in an often rapid downward trend of their population status. In this regard an ethnobotanical study on the medicinal plants of Shawar valley, District Swat was conducted with the aims to document medicinal plants and to examine the current status of the medicinal plants trade as well as the market chain starting from collectors to consumers. The survey reported 50 species of plants belonging to 33 families as ethnomedicinally important. These species were used as crud drugs by the local people and folk-lore for treating diseases in traditional system of medicine. The detailed local uses, recipe preparation along with their local names and diseases treated were recorded for each species.Market survey revealed that the structure of medicinal plant trade is complex and heterogeneous, involving many players. The collectors are often not aware of the high market prices and medicinal values, and most of the collected material is sold to local middlemen at a very low price. There was an increase of 3 to 5 folds in prices from collectors to the national market.Recommendations were given in the spheres of training sustainable harvesting and post harvesting of wild medicinal plant resources, trade monitoring, equitable sharing of benefits of wild resources, improved control on harvesting and trade for the conservation of resources, enhancement of cultivation efforts, future research into trade in wild harvested plants, community participation in natural resource management and value addition in the herbal products to maximize the benefits.